Elevated platelet count in patients with endometrial carcinoma: Correlation with selected prognostic factors and with survival

International Journal of Gynecological Cancer

Volumn 6, Issue 6, 1996, Pages 463-466

  Menczer, J ^a,b   Geva, D ^a   Schejter, E ^a   Zakut, H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

elevated platelet count; endometrial carcinoma; prognostic factors; survival; thrombocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; THROMBOCYTOSIS; UTERINE CERVIX CARCINOMA;

EID: 0029826850     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06060463.x     Document Type: Article

References (22)

1. Levin S, Conley CL. Thrombocytosis associated with malignant disease. Arch Int Med 1964; 114: 497-500.
2. Dutcher JA. Hematologic abnormalities in patients with non-hematologic malignancies. Hematol Oncol Clin North Am 1987; 1: 281-99.
3. Chalas E, Welshinger M, Engellener, W, Chumas J, Barbieri R, Mann WJ. The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 1992; 166: 974-7.
4. Zeimat AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994; 170: 549-54.
5. Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992; 69: 2975-7.
6. Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM. Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 1994; 74: 90-2.
7. Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 1994; 83: 445-8.
8. Rodriquez G. Does thrombocytosis have any significance in cervical cancer? Gynecol Oncol 1994; 55: 325-7.
9. Hernandez E, Heller PB, Whitney C, Diana K, Delgado G. Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study). Gynecol Oncol 1994; 55: 328-32.
10. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin: a potentiator of tumor cell metastasis. Cancer Res 1978; 47: 4130-3.
11. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984; 63: 55-63.
12. Honn KV, Tang DC, Crissman JD. Platelets and cancer metastasis: A causal relationship? Cancer Metastasis Rev 1992; 11: 325-51.
13. Menczer J, Krissi H, Chetrit A, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol 1995; 173: 774-8.
14. Park RC, Grigsby PW, Muss HB, Norris HS. Corpus epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia, J.B. Lippincott 1992; 663-93.
15. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
16. Lund B, Williamson P. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma. Obstet Gynecol 1990; 76; 617-22.
17. Suzuki A, Takahashi T, Nakamura K, et al. Thrombocytosis in patients with tumors producing colony-stimulating factor. Blood 1992; 80: 2052-9.
18. Higashihara M, Sunaga S, Tange T, Oohashi H, Kurokawa K. Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis. Cancer 1992; 70: 2105-8.
19. Blay JY, Favrot M, Rossi JF, Wijdenes J. Role of interleukin-6 in paraneoplastic thrombocytosis. Blood 1993; 82: 2261-2.
20. Xu FJ, Ramakrishnan S, Daly L, Soper JT, Berchuk A, Clark-Pearson D, Bast RC. Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol 1991; 165: 1356-62.
21. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet 1991; 164: 1038-43.
22. Woolas RP, Xu FJ, Jakobs IJ, et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst 1993; 85: 1748-50.